Toward a broader view of mechanisms of drug cardiotoxicity

Polina Mamoshina1, Blanca Rodriguez2, Alfonso Bueno-Orovio2

  • 1Deep Longevity Limited, Hong Kong.

Cell Reports. Medicine
|March 25, 2021
PubMed

Insights

Drug-induced cardiotoxicity affects the heart through various mechanisms beyond electrophysiology. This review explores drug-protein interactions involved in cardiotoxicity across diverse drug classes, highlighting shared pathways.

Area of Science:

  • Pharmacology
  • Cardiology
  • Toxicology

Background:

  • Cardiotoxicity is a frequent adverse drug effect impacting cardiac function.
  • Current preclinical testing primarily focuses on drug effects on cardiac electrophysiology.
  • However, many drugs also induce cardiotoxicity through mechanisms independent of electrophysiology.

Purpose of the Study:

  • To review key drug-protein interactions implicated in cardiotoxicity.
  • To discuss cardiotoxic mechanisms beyond electrophysiology.
  • To examine cardiotoxicity across various therapeutic drug classes.

Main Methods:

  • Literature review of drug-protein interactions and cardiotoxicity.
  • Analysis of adverse effects of anticancer, CNS, genitourinary, gastrointestinal, antihistaminic, anti-inflammatory, and anti-infective agents.
  • Identification of shared cardiotoxic mechanisms.

Main Results:

  • Numerous drugs can induce lethal arrhythmias by affecting cardiac electrophysiology.
  • A significant number of drugs impact cardiac function through non-electrophysiological pathways.
  • Shared mechanisms of cardiotoxicity include effects on contractility, mitochondrial function, and cellular signaling.

Conclusions:

  • Cardiotoxicity encompasses a broad range of cardiac dysfunctions induced by drugs.
  • Understanding drug-protein interactions is crucial for identifying and mitigating cardiotoxicity.
  • Diverse drug classes share common mechanisms of cardiotoxicity, necessitating comprehensive preclinical evaluation.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
98
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
917
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.5K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
654